BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Biomarker Technologies LLC To Present At 10th Annual International Pharma & Biotech Licensing Summit


10/19/2005 5:12:59 PM

PHOENIX--(BUSINESS WIRE)--March 10, 2005--Biomarker Technologies, the worldwide licensor of the blood diagnostic test for the early detection of breast cancer called the BT Test(TM), announced today that William Gartner, president and CEO, will participate in the Strategic Research Institute's 10th Annual International Pharma & Biotech Licensing Deal-Making Summit at Doubletree Paradise Valley Resort in Scottsdale, Ariz. The Summit is taking place March 29-31, 2005. Gartner will serve as a panelist addressing the volatile increases and decreases in the small and mid-cap biotech, diagnostic, and device market. The panel will also invoke past experiences as a look to the 2005 forecast. Gartner will present a newly conceived valuation tool developed by F. Randall Grimes at Biomarker Technologies headquarters. The Excel(R) data-graph macro allows strategic "what-if" evaluations to be performed simply by inputting estimated values. The peak ROI and per-share valuations can then be seen graphically.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES